Dai-ichi Karkaria Share Price

DaiIchi Karkaria Limited (DIK) was incorporated on 13 May 1960. The Company is engaged in manufacturing of Specialty Chemicals. The manufacturing activities of the Company are carried out from plants located at Dahej (Gujarat) and Kurkumbh (Maharashtra). The Company manufactures speciality chemicals has a tieup with Matsumoto to manufacture spin finishes, which are used for imparting lubrication and antistatic properties to textile filaments and yarns. It has enhanced the production capacity from 750 tons per annum to 3000 tons per annum.Over the past year, the company has focused on developing applicationled innovation, particularly in its priority segments. As part of this strategy, it has established an Application Development laboratory in the agriculture chemicals space, for strengthening customercentric product development and commercialization.DIK had set up a unit to manufacture certain bulk drugs omeprazole, menadione and calcium pentothenate, the last two will be manufactured in India for the first time.The expansion cum Diversification plan for High Molecular Weight Flocculants Project at Kurkumbh has been completed. Company had joint venture with project consultant for effluent treatment plants for increasing business. Company Bulk Drugs Fine Chemical Projects for patented molecule processes were developed and were scaled up to commercial level by March99. Company plans to start development of three new products in the pilot facility which is being upgraded presently to meet strict cGMP condition. Company also negotiating with foreign customer for product specific tieups in future. Company Spin fishes continue to do well POY DTY finish has been accepted in the market company hopes to get orders from leading synthetic fibre manufacturers.During the year 19992000, the companys successfully introduced eight new products in therapeutic areas of cardiovascular, antihistaminics, analgesics, anxiolytic, antidepressant and anticonsulgants.The Company introduced Emulsifier for Aqua flowables in pesticide formulations during 200102. The Pharmaceuticals business was transferred to Inogent Laboratories Pvt. Ltd., a Joint Venture with GVK Bio and Daiichi Karkaria Ltd., in October 2005.During the year 201011, the Company had formed a joint venture with CTI Chemicals Asia Pacific Pte. Ltd. (Subsidiary of Champion Technologies Inc.) and its wholly owned subsidiary Basic Oil Treating (India) Ltd. Through the formation of a Joint venture, the shareholding of Champion Daiichi Technologies India Ltd. was held by the Company and CTI Chemicals Asia Pacific Pte. Ltd. in the ratio of 50:50. Accordingly Champion Daiichi Technologies India Ltd. ceased to be a subsidiary of the Company w.e.f. 7th September, 2010.During the year 2018, Phase I (Oil Field Chemicals) of the Dahej Plant was commissioned. For Phase II (Alkoxylation Unit), the Company purchased from Buss Chem Tech AG, Switzerland. The Companys plant at Dahej, Gujarat was shut down from 25 March 2020 to 2 April 2020. To meet growing demand across key applications, Company is expanding its ethoxylation capacity. In 2025, Company launched new SC formulations and began thirdparty manufacturing of dispersants for WP and WDGs, expanding its downstream engagement into agrochemical business. In Home and Personal Care, it introduced biodegradable surfactants and EOfree emulsifiers for natural extract formulations. It launched an ecofriendly dispersant and commercialised two additional pigment stabilisers for green formulations in Paints Coatings business. In Textiles, it developed a new antistatic additive for polyester staple fibres.In FY26, the Company extended its ethoxylation capacity by adding a new EO reactor at the Dahej Plant.

For the full year FY2026–2027, revenue reached ₹165.95 crore and profit touched at ₹-3.24 crore.